Cas 866765-06-2,3-cyclopentyl-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-2-[4-(2-oxo-propane-1-sulfonyl)-phenyl]-propionamide

866765-06-2

Post Buying Request

Basic information

Product Name: 3-cyclopentyl-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-2-[4-(2-oxo-propane-1-sulfonyl)-phenyl]-propionamide
Synonyms: 3-cyclopentyl-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-2-[4-(2-oxo-propane-1-sulfonyl)-phenyl]-propionamide
CAS NO:866765-06-2
Molecular Formula:
Molecular Weight: 501.627
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-cyclopentyl-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-2-[4-(2-oxo-propane-1-sulfonyl)-phenyl]-propionamide(CAS DataBase Reference)
NIST Chemistry Reference: 3-cyclopentyl-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-2-[4-(2-oxo-propane-1-sulfonyl)-phenyl]-propionamide(866765-06-2)
EPA Substance Registry System: 3-cyclopentyl-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-2-[4-(2-oxo-propane-1-sulfonyl)-phenyl]-propionamide(866765-06-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 866765-06-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

866765-06-2 Suppliers

Recommended suppliers

866765-06-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 866765-06-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,6,7,6 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 866765-06:
(8*8)+(7*6)+(6*6)+(5*7)+(4*6)+(3*5)+(2*0)+(1*6)=222
222 % 10 = 2
So 866765-06-2 is a valid CAS Registry Number.

866765-06-2Upstream product

866765-06-2Downstream Products

866765-06-2Relevant academic research and scientific papers

THIAZOLOPYRIDINE DERIVATES, PHARMACEUTICAL CONDITIONS CONTAINING THEM AND METHODS OF TREATING GLUCOKINASE MEDIATED CONDITIONS

-

Page/Page column 30-31, (2010/02/14)

The present invention provides compounds of the formula (I) which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may b

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 866765-06-2